Skip to main content

Your search for “Lung Infection” returned 78 results

Tiny Swimming Robots Treat Deadly Pneumonia in Mice

September 22, 2022

UC San Diego engineers developed microrobots, that can swim around in the lungs, deliver medication and be used to clear up life-threatening cases of bacterial pneumonia. In mice, the microrobots safely eliminated pneumonia-causing bacteria in the lungs and resulted in 100% survival.

Human Mini-Lungs Grown in Lab Dishes are Closest Yet to Real Thing

August 31, 2021

UC San Diego researchers developed first-of-their-kind lung organoids that include all cell types that make up the organ, allowing for “Phase 0” testing of new treatments for respiratory infections such as COVID-19.

Phage Trial to Treat CF Patients With Multi-Drug Resistant Bacterial Infections

October 11, 2022

UC San Diego scientists are leading a national early-stage clinical trial to assess the safety and efficacy of using bacteriophages to treat drug-resistant bacterial infections in cystic fibrosis patients.

How a Plant Virus Could Protect and Save Your Lungs From Metastatic Cancer

September 14, 2021

Using a virus that grows in black-eyed pea plants, researchers developed a new therapy that could keep metastatic cancers from spreading to the lungs, as well as treat established tumors in the lungs.

Modifier Gene May Explain Why Some with Cystic Fibrosis are Less Prone to Infection

December 10, 2019

People with cystic fibrosis who carry genetic variants that lower RNF5 gene expression have more mutant CFTR protein on cell surfaces. Even if the CFTR protein isn’t fully functional, it’s better than none, and may explain why some with cystic fibrosis are less prone to infection than others.

AI Predicts How Patients with Viral Infections, Including COVID-19, Will Fare

June 11, 2021

UC San Diego School of Medicine researchers discovered gene expression patterns associated with pandemic viral infections, providing a map to help define patients’ immune responses, measure disease severity, predict outcomes and test therapies — for current and future pandemics.

Arthritis Drug Presents Promise as Treatment for COVID-19 Pneumonia

April 29, 2020

UC San Diego Health has launched a Phase III clinical trial to assess whether a medication used to treat rheumatoid might also have therapeutic value for patient with COVID-19 who have developed or are at high risk of developing serious lung damage from SARS-CoV-2 infections.

Post-COVID Lung Disease Shares Origins with Other Scarring Lung Disorders

July 20, 2022

UC San Diego researchers provide first insights into the fundamental cellular pathologies that drive interstitial lung disease in patients post-COVID.

Supercomputer Simulations Help Combat Tuberculosis (TB) Granulomas

March 20, 2019

Researchers from the University of Michigan relied on supercomputers at UC San Diego and elsewhere to help them develop detailed models to better understand how TB spreads throughout the lungs.

UC San Diego Pharmacist’s Work Helps Save Lives Across the Globe

August 27, 2020

…with COVID-19, a viral infection, may be prescribed vancomycin due to the critical nature of their illness. “What often happens is a patient who spends a long time in the hospital may develop blood or lung infections with antibiotic-resistant bacteria known as MRSA—that’s short for methicillin-resistant Staphylococcus aureus, sometimes also…

Category navigation with Social links